Patients (n=64) | Controls (n=31) | |
---|---|---|
age (mean ±SD) | 48.7±12.5 | 46.2±13.4 |
Sex (female/male) | 53/11 | 26/5 |
BMI( kg/m2) | 27.0±5.0 | 27.5±4.7 |
Duration of the disease (years) | 6.5 (0.50-34) | |
Duration of MTX treatment (years) | 2 (0.2-10) | |
Concurrent DMARD treatment (n) (%) | 34 (53.1%) | |
Rheumatoid factor positivity (n)(%) | 41( 64.1%) |